Silvana Konermann

So you have to be a little patient.

But I think that within four years, five years, we will be able to have these models that are accurate enough to be useful.

And then it's a totally different way of doing biology.

It's not kind of

one hypothesis at a time.

A field like Alzheimer's can get really bogged down by just focusing on one dominant hypothesis that might be wrong.

And with these models, you can actually take a comprehensive, data-driven look.

Out of all the things that we could be targeting with a drug, what's going to happen with all of them, and then which of them is going to be the most effective one?

It's just a totally different way of tackling the problem that I think is so exciting.